Immuno-Oncology
Immunotherapy Plus Chemo Improves Metastatic TNBC Outcomes
BY GINA COLUMBUS
Advanced NSCLC: Expert Talks Recent Advancements, Shortcomings
BY BRIELLE BENYON
More Immunotherapy May Enter TNBC Space
BY JESSICA HERGERT
Nurse Offers Advice on Discussing AEs With Patients
BY KATHLEEN MADDEN, MSN, RN, APHN, AOCNP, FNP-BC
New Combos Are Coming to the Melanoma Space
BY MARIO SZONL, MD
Managing irAEs is a Dynamic Discussion
BY BRIELLE BENYON AND GINA COLUMBUS
Monitor Toxicities When Treating Breast Cancer With Immunotherapy
BY LEISHA A. EMENS, MD, PHD
Practical Considerations for Adjuvant vs. Neoadjuvant Immunotherapy in NSCLC
BY JUSTIN GAINOR, MD
Better Biomarkers Needed for mRCC Treatment Planning
BY BRIELLE BENYON
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.